C-Mer Medical Holdings Ltd
C-Mer Medical Holdings's GHG Emissions Data Preview
In 2023, C-Mer Medical Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
C-Mer Medical Holdings has also provided a category-level breakdown for 2 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
aVerified Sources Behind C-Mer Medical Holdings’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore C-Mer Medical Holdings’s data sources below and access millions more through our Disclosure Search.
Insights into C-Mer Medical Holdings's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of C-Mer Medical Holdings amounted to 4,374.47 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of C-Mer Medical Holdings increased by 13.52%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
C-Mer Medical Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are C-Mer Medical Holdings's Scope 1 emissions?
In 2023, the total Scope 1 emissions of C-Mer Medical Holdings were 60.37 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), C-Mer Medical Holdings's Scope 1 emissions decreased by 14.61%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are C-Mer Medical Holdings's Scope 2 emissions?
In 2023, C-Mer Medical Holdings reported Scope 2 greenhouse gas (GHG) emissions of 4,314.1 tCO₂e without specifying the calculation method. a
Has C-Mer Medical Holdings reduced its Scope 2 emissions over time?
Since 2020, C-Mer Medical Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 182.84%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), C-Mer Medical Holdings's Scope 2 emissions (Unspecified Calculation Method) rose by 14.04% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does C-Mer Medical Holdings use for Scope 2 reporting?
In 2023, C-Mer Medical Holdings reported its Scope 2 emissions using an unspecified methodology. a
C-Mer Medical Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into C-Mer Medical Holdings's Value Chain Emissions
In 2023, C-Mer Medical Holdings reported 92.61 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2023 disclosure of C-Mer Medical Holdings includes a breakdown across 2 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
C-Mer Medical Holdings's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are C-Mer Medical Holdings's Scope 3 emissions?
In 2023, C-Mer Medical Holdings reported total Scope 3 emissions of 92.61 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a
Has C-Mer Medical Holdings reduced its Scope 3 emissions over time?
Since 2020, C-Mer Medical Holdings's Scope 3 emissions have increased by 125.27%, reflecting a rising long-term trend in Scope 3 emissions over time. a b
Compared to the previous year (2022), C-Mer Medical Holdings's Scope 3 emissions increased by 30.79%, suggesting that the company faced challenges in reducing emissions across its value chain. a
What categories of Scope 3 emissions does C-Mer Medical Holdings disclose?
In 2023, C-Mer Medical Holdings reported emissions for 2 out of the 15 Scope 3 categories defined by the GHG Protocol. a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
What are the main sources of C-Mer Medical Holdings's Scope 3 emissions?
In 2023, the largest contributors to C-Mer Medical Holdings's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 72.09 tCO₂e (77.84%)
- Business Travel (Cat. 6): 20.52 tCO₂e (22.16%)
C-Mer Medical Holdings's Scope 3 Emissions by Categories
Insights into C-Mer Medical Holdings’s GHG Emissions Intensity Compared to Industry Peers
In 2023, C-Mer Medical Holdings reported Scope 1 greenhouse gas (GHG) emissions of 60.37 tCO₂e and total revenues of USD 246 millions. This translates into an emissions intensity of 0.25 tCO₂e per millions USD. a
C-Mer Medical Holdings's Scope 1 Emissions Intensity Compared to Peers
How does C-Mer Medical Holdings's GHG emissions intensity compare to its peers?
In 2023, C-Mer Medical Holdings reported a Scope 1 emissions intensity of 0.25 tCO₂e per millions USD. Compared to the peer group median of 5.09 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does C-Mer Medical Holdings rank on GHG emissions intensity within its industry?
In 2023, C-Mer Medical Holdings ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places C-Mer Medical Holdings among the top performers, with one of the lowest emissions intensities relative to peers. a
Insights into C-Mer Medical Holdings's Total Carbon Footprint
In 2023, C-Mer Medical Holdings reported a total carbon footprint of 4,467.08 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 13.83% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to C-Mer Medical Holdings's total carbon footprint was Scope 2 emissions, accounting for 96.58% of the company's total carbon footprint, followed by Scope 3 emissions at 2.07%. a